Visualitza per autor "Yu, Jason"
Ara mostrant els elements 1-1 d 1
-
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors
Dunn, Shanade; Eberlein, Cath; Yu, Jason; Ong, Swee Hoe; Yelland, Urs; Serra Elizalde, Violeta; Gris Oliver, Albert (Springer Nature, 2022-11-11)